ArticleHeliyon2024

Developing a dormancy-associated ECM signature in TNBC that is linked to immunosuppressive tumor microenvironment and selective sensitivity to MAPK inhibitors.

Yang Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.